Cargando…

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study

BACKGROUND: Only a few patients with pancreatic ductal adenocarcinoma (PDAC) recurring after curative resection and peri-operative (neoadjuvant and adjuvant) therapy are included in clinical trials of metastatic PDAC. As such, there is a paucity of data to guide treatment after relapse, and patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gbolahan, Olumide B., Tong, Yan, Sehdev, Amikar, O’Neil, Bert, Shahda, Safi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525379/ https://www.ncbi.nlm.nih.gov/pubmed/31101022 http://dx.doi.org/10.1186/s12885-019-5630-4

Ejemplares similares

Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care
por: Sehdev, Amikar, et al.
Publicado: (2013)

Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer
por: Kays, Joshua K., et al.
Publicado: (2018)

Primary Small Cell Carcinoma of the Tonsil: A Case Report and Review of the Literature
por: Sehdev, Amikar, et al.
Publicado: (2012)

Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence
por: Olatunji, Gbolahan, et al.
Publicado: (2023)

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer
por: Davis, S. Lindsey, et al.
Publicado: (2019)

Metachronous gastric metastasis from lung primary, with synchronous pancreatic neuroendocrine carcinoma
por: El Hajj, Ihab I., et al.
Publicado: (2018)

Time to treatment initiation and its impact on real‐world survival in metastatic colorectal cancer and pancreatic cancer
por: Gbolahan, Olumide, et al.
Publicado: (2022)

Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-Free, and Relative Survival
por: Shin, Dong Wook, et al.
Publicado: (2021)

Overall Survival in Patients With Resected Glioblastoma Treated With Adjuvant Therapy: A Retrospective Study in a Public Hospital in Chile
por: San Martin, Evelyn, et al.
Publicado: (2021)

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Pancreatic adenocarcinomas with mature blood vessels have better overall survival
por: Katsuta, Eriko, et al.
Publicado: (2019)

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel
por: Bianconi, Daniela, et al.
Publicado: (2017)

Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
por: Gu, Dongsheng, et al.
Publicado: (2018)

Pre-treatment DWI as a predictor of overall survival in locally advanced pancreatic cancer treated with Cyberknife radiotherapy and sequential S-1 therapy
por: Zhang, Yu, et al.
Publicado: (2018)

Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis
por: Paluri, Ravi Kumar, et al.
Publicado: (2023)

Neutrophil and lymphocyte counts at diagnosis are associated with overall survival of pancreatic cancer: A retrospective cohort study
por: Xiao, Yuanyuan, et al.
Publicado: (2016)

APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1–STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival
por: Cardoso, Angelo A., et al.
Publicado: (2012)

Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial
por: Mosher, Catherine E., et al.
Publicado: (2021)

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
por: Goldstein, David, et al.
Publicado: (2020)

Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2019)

Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
por: Weber, Jeffrey S., et al.
Publicado: (2022)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Varying postresection lactate dehydrogenase with overall survival of early stage pancreatic cancer patients: A retrospective study
por: Xiao, Yuanyuan, et al.
Publicado: (2017)

Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia
por: Talbot, Alice, et al.
Publicado: (2023)

A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer
por: McKay, Rana R., et al.
Publicado: (2020)

Correction to: Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
por: Weber, Jeffrey S., et al.
Publicado: (2022)

A phase I evaluation of the effect of curcumin on dose‐limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors
por: Gbolahan, Olumide B., et al.
Publicado: (2022)

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma
por: Oshima, Sonoko, et al.
Publicado: (2023)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Retraction Note: Pre-treatment DWI as a predictor of overall survival in locally advanced pancreatic cancer treated with Cyberknife radiotherapy and sequential S-1 therapy
por: Zhang, Yu, et al.
Publicado: (2018)

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
por: Golan, T, et al.
Publicado: (2014)

Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
por: Xiao, Yuanyuan, et al.
Publicado: (2019)

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
por: Haas, Michael, et al.
Publicado: (2017)

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023)

The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort
por: Dong, Xiaotao, et al.
Publicado: (2023)

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
por: Yang, Shih-Hung, et al.
Publicado: (2017)

Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
por: Hwang, Eu Chang, et al.
Publicado: (2014)

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
por: Li, Wanwan, et al.
Publicado: (2019)

Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study
por: Bauer, Katrin, et al.
Publicado: (2023)

Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients
por: Chen, Huiming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pd7qa29gthp26h1g83bl2lodna